Laura Beauregard

Evolving with Purpose Expanding Our Leadership, Building on 35 Years of Quality Clinical research is changing. Study designs are becoming more complex, data ecosystems are expanding, and sponsors and research organizations are being asked to deliver more with greater efficiency, collaboration, and oversight than ever before. As the industry evolves, so does DFnet. For more […]

DIA 2026: Doing More with Less Starts with Better Data DIA 2026 brought together leaders from across life sciences, clinical research, regulatory affairs, technology, and patient advocacy to discuss how the industry can move promising science forward faster while maintaining the quality, trust, and rigor required to support better health outcomes. DFnet CEO Amy Apostoleris

Investing in the Future of Clinical Trials: Welcoming Emily MacKenzie as VP of Software & Technology We’re pleased to share that Emily MacKenzie is joining DFnet as Vice President of Software & Technology. As clinical trials evolve, teams are being asked to manage more complexity, more data sources, and higher expectations for quality and oversight.

Lessons Learned from SCOPE Summit 2026: The Industry Is Optimizing for Execution SCOPE Summit 2026 reinforced something we see every day in real trial delivery. The next phase of transformation in clinical operations will not be defined by bold promises, but by what actually works. Across sessions and conversations, the tone was noticeably more execution

DFnet CEO Amy Apostoleris Recognized Among Top 100 Innovators & Entrepreneurs DFnet is proud to congratulate our CEO, Amy Apostoleris, on being named to the Top 100 Innovators & Entrepreneurs list, a global recognition honoring leaders who are driving meaningful innovation and impact across industries. With more than 30 years of experience spanning pharmaceutical, biotech,